ESR1 and breast carcinoma: As initial step, the capacity of proliferation induction was evaluated on breast cancer cell lines ER+ MCF-7 and T-47D that were transfected with an antagomir against miR-190b and on ER− MD-MBA-231 that was transfected with a miR-190b mimic.